Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015514 |
---|---|
Receipt number | R000018023 |
Scientific Title | Parallel group controlled, dose-escalation study to assess the safety, tolerability, efficacy of YS-1402 combined with CABG for patient with ischaemic cardiomypathy |
Date of disclosure of the study information | 2015/06/01 |
Last modified on | 2020/08/17 15:20:56 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/10/23 15:52:32 | ||
2 | Update | 2015/03/23 15:53:08 | Public title |
|
3 | Update | 2015/03/23 15:57:03 | Interventions/Control_1 Interventions/Control_2 Interventions/Control_3 Key inclusion criteria |
|
4 | Update | 2015/03/31 12:00:45 | UMIN ID1 |
|
5 | Update | 2015/04/23 10:39:27 | Last name of contact person Last name of contact person Organization Organization Category of Funding Organization |
|
6 | Update | 2015/04/23 10:39:48 | Anticipated trial start date |
|
7 | Update | 2015/10/23 09:55:37 | Randomization unit |
|
8 | Update | 2015/10/23 09:56:35 | Recruitment status Anticipated trial start date |
|
9 | Update | 2016/04/25 10:02:22 | Name of primary person or sponsor Organization Category of Funding Organization |
|
10 | Update | 2017/04/25 10:43:47 | Last name of lead principal investigator Last name of lead principal investigator |
|
11 | Update | 2019/05/07 10:45:31 | Recruitment status Date of IRB Last follow-up date |
|
12 | Update | 2020/08/17 15:20:56 | Recruitment status |